Amanta Healthcare Ltd (AMANTA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Amanta Healthcare Ltd on NSE and BSE, with an AI summary of each filing.
submission of Audio Recording of Post Results Conference Call held on November 4, 2026
Audio / Video · 04 Nov 2026, 11:24 pm
Amanta Healthcare Releases Audio Recording of Post-Earnings Conference Call Amanta Healthcare Limited informed stock exchanges that the audio recording of its post-results conference call held on 4th Nov'26 has been made available on the company's official website. Investors can access the recording directly via the company's dedicated investor relations portal under the investor meet section.
Monitoring Agency Report for the quarter ended September 30, 2026
Others (Uncategorized) · 04 Nov 2026, 7:23 pm
Amanta Healthcare Reports Q2FY27 IPO Proceeds Utilization and Capex Delays CRISIL Ratings issued the Monitoring Agency Report for Amanta Healthcare for the quarter ended 30th Sep'26 regarding its Rs 12,600 lakh IPO proceeds. Total utilization reached Rs 10,082.69 lakh, leaving Rs 2,517.31 lakh unutilized, primarily deployed in bank fixed deposits. Net capex deployment across SteriPort and SVP manufacturing lines stood at Rs 7,495.43 lakh versus the original Rs 8,000 lakh FY26 estimate, reflecting project implementation delays due to supplier terms finalization and delayed work completion. No deviation was reported in issue objects.
Announcement under Regulation 30 - Investor Presentation
Investor Presentation · 04 Nov 2026, 5:33 pm
Amanta Healthcare Reports Strong Q2 FY27 Growth and Commissioning of SteriPort Line 3 Amanta Healthcare posted Q2 FY27 revenue of ₹83.13 Cr, up 17.3% YoY, with EBITDA at ₹17.95 Cr (21.6% margin) and PAT rising 303% YoY to ₹4.86 Cr. H1 FY27 revenue reached ₹151.94 Cr with PAT of ₹8.17 Cr. SteriPort Line 3 was commissioned in early Sep'26, expanding capacity by 75% to 11.6 Cr bottles and targeting ~₹60 Cr FY27 revenue. Upcoming SVP expansion in Q1 FY28 will boost capacity to 31.7 Cr units, supporting management's medium-term target of 20%+ revenue CAGR and 25%+ EBITDA margin.
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Press Release
Press Release · 04 Nov 2026, 4:58 pm
Amanta Healthcare Reports Strong Q2FY27 Results With Operational Expansion Amanta Healthcare reported a 17.3% YoY revenue rise to ₹83.13 crore in Q2FY27, while EBITDA increased 21.9% YoY to ₹17.95 crore, expanding margins by ~80 bps to 21.6%. PAT jumped to ₹4.86 crore from ₹1.21 crore in Q2FY26. H1FY27 revenue reached ₹151.94 crore with PAT of ₹8.17 crore. The commissioned SteriPort Line 3 expanded capacity by 75% to 11.6 crore bottles, targeting ~₹60 crore FY27 revenue contribution. Further Small Volume Parenteral capacity expansion is targeted for Q1FY28, while a 10.8 MW captive solar plant yields ~₹9 crore annual savings.
Statement of deviation or variation in utilization of funds, if any, under Regulation 32 of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 03 Nov 2026, 11:07 pm
Amanta Healthcare Reports Zero Deviation in IPO Proceeds Utilization for Sep'26 Quarter Amanta Healthcare confirmed zero deviation in utilizing its ₹126 crore IPO proceeds for the quarter ended 30th Sep'26. Monitored by CRISIL Ratings, cumulative deployment reached ₹67.02 crore of the ₹70.00 crore allocated for the SteriPort manufacturing line capex and ₹7.94 crore of the ₹30.13 crore earmarked for the SVP line capex at Hariyala, Gujarat. Issue expenses were fully utilized at ₹22.85 crore (adjusted for GST), with general corporate purpose deployment at ₹3.02 crore.
Amanta Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 03 Nov 2026, 11:00 pm
To approve unaudited Financial Results for quarter and half year ended September 30, 2026
Financial Result · 03 Nov 2026, 10:54 pm
To approve unaudited Financial Results for quarter and half year ended 30th September 2026.
Outcome · 03 Nov 2026, 10:46 pm
Amanta Healthcare Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 8,313 (+17.3% YoY | +20.8% QoQ) ■ EBITDA: 1,719 (+17.4% YoY | +18.3% QoQ) ■ EBITDA Margin (%): 20.7 (+2 bps YoY | -45 bps QoQ) ■ PAT: 486 (+302.6% YoY | +46.8% QoQ) ■ EPS (INR): 1.25 (+303.2% YoY | +47.1% QoQ)
Intimation of Schedule of the Earnings Conference Call for Q2 ended September 30, 2026
Intimation · 04 Nov 2026, 3:00 pm
Amanta Healthcare Schedules Q2 & H1 FY27 Earnings Call Amanta Healthcare Limited will host its Q2 and H1 FY27 earnings conference call on 4th Nov'26 at 03:00 PM IST, hosted by Go India Advisors. Senior management, including Managing Director & Chairman Bhavesh Patel and CFO Paras Mehta, will discuss the company's financial performance and business updates for the period ended 30th Sep'26. Investors can access the call via universal dial-in numbers +91 22 6280 1557 or +91 22 7115 8383, with pre-registration required.
Announcement under Regulation 30 (LODR) - Resignation of Senior Management Personnel
Change in Management · 30 Oct 2026, 4:25 pm
Amanta Healthcare COO Anil Rathi Resigns Effective 29th Oct'26 Amanta Healthcare Limited announced the resignation of its Chief Operating Officer, Anil Rathi, categorized as Senior Management Personnel under SEBI Listing Regulations. The resignation took effect immediately on 29th Oct'26. According to the regulatory disclosure, Rathi stepped down to pursue better career opportunities and professional growth.
Amanta Healthcare Limited has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business.
Intimation · 03 Nov 2026, 5:30 am
To consider and approve the financial results for the quarter and half year ended September 30, 2026
Intimation · 03 Nov 2026, 5:30 am
Amanta Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Board Meeting to consider ....
Intimation · 03 Nov 2026, 5:30 am
Amanta Healthcare Board to Consider Q2 and H1 Results on Nov 3, 2026 Amanta Healthcare Limited announced that a meeting of its Board of Directors is scheduled for 3rd Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the company stated that its trading window, which closed on 1st Oct'26 under SEBI insider trading regulations, will reopen on 6th Nov'26.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pravinchandra Mehta
Acquisition/ Disposal of Shares · 05 Oct 2026, 3:32 pm
Amanta Healthcare Promoter Pravinchandra Mehta Gifts 4.46% Stake Pravinchandra Dhanjibhai Mehta, a promoter group member of Amanta Healthcare Limited, transferred 17,32,763 equity shares representing a 4.46% voting stake to his nephew, Shailesh Mansukhlal Mehta, via an off-market gift on 30th Sep'26. Following this disposal, Pravinchandra Mehta’s shareholding in the company decreased from 18,32,363 shares (4.72%) to 99,600 shares (0.26%). Amanta Healthcare's total equity share capital remains unchanged at 3,88,29,351 equity shares of Rs. 10 each.
Submission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 - Off-Market Transfer of Equity shares
Others (Uncategorized) · 01 Oct 2026, 5:26 pm
Amanta Healthcare Promoter Group Member Transfers Shares via Off-Market Gift Amanta Healthcare disclosed an off-market share transfer under SEBI PIT Regulations by promoter group member Pravinchandra Dhanjibhai Mehta. On 30th Sep'26, Mehta disposed of 17,32,763 equity shares as a gift to a relative for nil consideration. Consequently, Mehta's shareholding in the company decreased from 18,32,363 shares (4.72%) to 99,600 shares (0.26%).
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kirit Desai
Acquisition/ Disposal of Shares · 01 Oct 2026, 4:03 pm
Amanta Healthcare Promoter Kirit Desai Acquires 0.39% Stake via Inter-Se Transfer Kirit Ambalal Desai, a promoter group member of Amanta Healthcare Limited, acquired 1,50,400 equity shares (0.39% voting rights) on 28th Sep'26 via an off-market inter-se transfer from promoter group member Pravinchandra Dhanjibhai Mehta at Rs. 190 per share. Following this transaction, Desai’s stake increased from 11,27,079 shares (2.90%) to 12,77,479 shares (3.29%). Total promoter group shareholding remains unchanged as the transaction was an internal transfer.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pravinchandra Mehta
Acquisition/ Disposal of Shares · 30 Sept 2026, 10:25 pm
Amanta Healthcare Promoter Group Inter-Se Equity Transfer Pravinchandra Dhanjibhai Mehta, a promoter group member of Amanta Healthcare Limited, disposed of 1,50,400 equity shares (0.39% voting capital) on 28th Sep'26 via an off-market inter-se transfer to fellow promoter group member Kirit Ambalal Desai at Rs. 190 per share. Following the transaction, Mehta's shareholding decreased from 19,82,763 shares (5.11%) to 18,32,363 shares (4.72%). Overall promoter group aggregate shareholding in the company remains unchanged.
Submission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 - Off Market transfer of equity shares
Others (Uncategorized) · 30 Sept 2026, 5:51 pm
Amanta Healthcare Promoter Group Executes Off-Market Equity Share Transfer Amanta Healthcare disclosed an inter-se promoter group off-market transaction executed on 28th Sep'26. Promoter group member Pravinchandra Dhanjibhai Mehta sold 1,50,400 equity shares valued at ₹2,85,76,000, reducing his stake from 19,82,763 shares (5.11%) to 18,32,363 shares (4.72%). Concurrently, promoter group member Kirit Ambalal Desai acquired the 1,50,400 equity shares for ₹2,85,76,000, increasing his holding from 11,27,079 shares (2.90%) to 12,77,479 shares (3.29%). No derivative transactions were reported.
Scrutinizer''s Report and E-voting Results - Outcome of AGM
Annual General Meeting · 17 Sept 2026, 1:21 am
Scrutinizer''s Report and E-Voting results for the 31st Annual General Meeting of the Company
Annual General Meeting · 17 Sept 2026, 12:32 am
Announcement under Regulation 30 (LODR) - change in management
Change in Management · 16 Sept 2026, 11:37 pm
Amanta Healthcare Approves Director Re-appointment and Secretarial Auditor at 31st AGM Amanta Healthcare Limited shareholders approved key resolutions at the 31st Annual General Meeting held on 16th Sep'26. Members approved the re-appointment of Non-Executive, Non-Independent Director Mr. Nimesh P. Patel (retiring by rotation), who has served on the board since 14th Dec'20. Additionally, shareholders approved the appointment of Ahmedabad-based M/s. Kashyap R. Mehta & Partners, Practicing Company Secretaries, as Secretarial Auditors for a 5-year term spanning FY 2026-27 through FY 2030-31.
Proceedings of the 31st Annual General Meeting ("AGM")
Annual General Meeting · 16 Sept 2026, 10:03 pm
Newspaper publication
Others (Uncategorized) · 03 Sept 2026, 10:27 pm
Amanta Healthcare Announces Special Window for Share Dematerialization Amanta Healthcare Limited published advertisements in Business Standard and Jai Hind on 3rd Sep'26 notifying shareholders of a special window for the transfer and dematerialization of physical shares. Complying with SEBI's 30th Jan'26 circular, this initiative accelerates the conversion of physical equity certificates into electronic format. This regulatory step ensures compliance, streamlines shareholder records, mitigates fraud risks associated with physical holdings, and ensures seamless market tradability for the company's stock across both BSE and NSE platforms.
Amanta Healthcare Limited Announces Commissioning of New SteriPort Line
Others (Uncategorized) · 02 Sept 2026, 11:09 pm
Intimation - Regulation 36(1)(b) of the SEBI Listing Regulations
Others (Uncategorized) · 25 Aug 2026, 10:20 pm
Amanta Healthcare Schedules 31st AGM and Releases FY26 Annual Report Amanta Healthcare has scheduled its 31st Annual General Meeting (AGM) for 16th Sep'26 at 12:00 PM IST, to be held via video conferencing. The company has released its integrated Annual Report for the financial year 2025-26, which is now available on its website. This communication also serves as a reminder for shareholders holding physical securities to update their KYC details and dematerialize holdings, a mandatory requirement for receiving payments like dividends from 01st Apr'24, as per SEBI regulations.